Carlyle to buy J&J diagnostic unit for $4.15 bln

January 16, 2014

Jan 16 (Reuters) - Private equity firm Carlyle Group said it would buy Johnson & Johnson's diagnostics unit for $4.15 billion.

Carlyle said the deal was expected to close in the middle of 2014.

Reuters reported in December that Carlyle was nearing an agreement to acquire Johnson & Johnson's ortho clinical diagnostics unit for about $4 billion.